ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Novartis chief’s 2018 take-home pay suffers—not from Cohen but from low-grade returns
February 24, 2019Novartis CEO Vas Narasimhan navigated through a tough and transitional year at the drugmaker, racking up almost $10 million in salary, incentive pay and equity awards for his efforts. But his 2018 take-home pay took a hit on longer-term shareholder return
Pharma Sources Insight January 2025
